Evidence map›Paper›PMID 30457530›Full record

ArticleEmerging infectious diseases2018

Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant.

Siddharth Sridhar, Cyril C Y Yip, Shusheng Wu, Jianpiao Cai, Anna Jin-Xia Zhang, Kit-Hang Leung, Tom W H Chung, Jasper F W Chan, Wan-Mui Chan, Jade L L Teng and 8 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Emerging infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 4 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 4 syntheses or guidelines pooled it, 260 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Performance of Elecsys Anti-HEV IgG and IgM Assays for the Detection of Acute, Recent or Past Hepatitis E Virus Infection.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Siddharth Sridhar
Cyril C Y Yip
Shusheng Wu
Jianpiao Cai
Anna Jin-Xia Zhang
Kit-Hang Leung
Tom W H Chung
Jasper F W Chan
Wan-Mui Chan
Jade L L Teng
Rex K H Au-Yeung
Vincent C C Cheng
Honglin Chen
Susanna K P Lau
Patrick C Y Woo
Ning-Shao Xia
Chung-Mau Lo
Kwok-Yung Yuen
University of Hong Kong - Shenzhen Hospital · CNUniversity of Hong Kong · HKXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

All hepatitis E virus (HEV) variants reported to infect humans belong to the species Orthohepevirus A (HEV-A). The zoonotic potential of the species Orthohepevirus C (HEV-C), which circulates in rats and is highly divergent from HEV-A, is unknown. We report a liver transplant recipient with hepatitis caused by HEV-C infection. We detected HEV-C RNA in multiple clinical samples and HEV-C antigen in the liver. The complete genome of the HEV-C isolate had 93.7% nt similarity to an HEV-C strain from Vietnam. The patient had preexisting HEV antibodies, which were not protective against HEV-C infection. Ribavirin was an effective treatment, resulting in resolution of hepatitis and clearance of HEV-C viremia. Testing for this zoonotic virus should be performed for immunocompromised and immunocompetent patients with unexplained hepatitis because routine hepatitis E diagnostic tests may miss HEV-C infection. HEV-C is also a potential threat to the blood product supply.

Indexed as

Hepatitis E virusTransplant RecipientsAnimalsAntiviral AgentsGenome, ViralGenomicsHepatitis EHumansLiver TransplantationMaleMiddle AgedOpen Reading FramesRatsTreatment OutcomeViral LoadWhole Genome SequencingAntiviral Agentschronic hepatitishepatitishepatitis EHEVHong Kongimmunocompromisedliver transplantrat hepatitis E virusrodentsviruseszoonoses

Identifiers

PMID30457530
PMCPMC6256372
OpenAlexW2899989846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.